Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
2017 · Science · 5,249 citations
https://doi.org/10.1126/science.aan3706
E
Emmanuelle Le Chatelier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
18.1K
Citations
36
h-index
55
i10-index
Emmanuelle Le Chatelier is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Gut microbiota and health & Diet and metabolism studies & Clostridium difficile and Clostridium perfringens research. The author has an h-index of 36, co-authored 90 publications.
ORCID: 0000-0002-2724-0536Papers by this author
worksGut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
2017 · Science · 4,526 citations
https://doi.org/10.1126/science.aan4236
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
2017 · Genome biology · 378 citations
https://doi.org/10.1186/s13059-017-1271-6
Specific gut microbiota features and metabolic markers in postmenopausal women with obesity
2015 · Nutrition and Diabetes · 309 citations
https://doi.org/10.1038/nutd.2015.9
Combinatorial, additive and dose-dependent drug–microbiome associations
2021 · Nature · 224 citations
https://doi.org/10.1038/s41586-021-04177-9
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
2021 · Journal of Hepatology · 203 citations
https://doi.org/10.1016/j.jhep.2021.09.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat